from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0213c/-

LFCtreatmentdescriptionclass of inhibitor

0.109

Amikacinug/mL Amikacintranslation

0.197

Cap5-10ug/mL Capreomycintranslation

0.661

Rox10-50 ug/mL Roxithromycintranslation

0.194

SM2-5 ug/mL Streptomycintranslation

-0.058

Tet5-10 ug/mL Tetracyclinetranslation

0.315

Rif0.2-5ug/mL Rifampicintranscription

0.469

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.293

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.367

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.252

Clofazimine10-13 ug/mL Clofaziminerespiration

0.235

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.272

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.384

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.238

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.140

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.981

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.744

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.783

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.205

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.859

KCN5-20 ug/mL Potassium cyaniderespiration

-0.038

NaN30.2-2 mM Sodium aziderespiration

-0.565

Nigericin50 uM Nigericinrespiration

1.022

TRC10-150 ug/mL Triclosanrespiration

-0.244

TRZ10-25 ug/mL Thioridazinerespiration

-0.599

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

3.504

menadione6-10 ug/mL Menadionerespiration

0.870

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.267

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.427

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.159

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.986

NRP_1Non-replicating persistence stage 1dosRassociated

0.060

Amp0.2mg/mL AmpicillincellWall

-0.361

Cephalexin20-100 ug/mL CephalexincellWall

-0.099

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.349

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.016

EMB10-20 ug/mL EthambutolcellWall

-0.169

Eta12-40 ug/mL EthionamidecellWall

-0.205

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.339

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.174

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.224

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.117

BZA0.12 mg/mL BenzamidearomaticAmides

0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.632

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.195

H2O24 mM hydrogen peroxideDNAdamaging

0.010

Levo10 ug/mL LevofloxacinDNAdamaging

-0.381

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.291

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.276

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.351

UVUV-irradiationDNAdamaging

0.314

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.347

Antimycin12.5-50 ug/mL Antimycin A?

-0.333

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.163

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.226

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.556

PA8240.2-2 ug/mL PA-824?

-1.041

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.418

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.376

Verapamil50 uM Verapamil?

-0.880

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.706

methoxatin10-20 ug/mL Methoxatin?